- Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumorsEduardo Vilar
Department of Medical Oncology, Vall d Hebron University Hospital, Barcelona 08035, Spain
Endocr Relat Cancer 14:221-32. 2007..Also a comprehensive review of the literature about chemotherapy in NETs is presented...
- A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumorsEduardo Vilar
Department of Medical Oncology, Vall d Hebron University Hospital, Ps Vall d Hebron, 119 129, 08035 Barcelona, Spain
Invest New Drugs 30:299-305. 2012..A phase I study was performed in patients with advanced solid tumors to determine the maximum tolerated dose (MTD), establish a safety profile, and to evaluate pharmacokinetics and efficacy of the drug...